Article Per Year (5 Year)
p-Index From 2020 - 2025
0.23
P-Index
This Author published in this journals
All Journal Medical Journal of Indonesia
Shamshirian, Danial
Unknown Affiliation
Medicine & Pharmacology

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
Effects of edaravone on hypoxia-induced lethality in male Swiss albino mice Shaki, Fatemeh; Mokhtaran, Mina; Raei, Maedeh; Razavi, Alireza; Shamshirian, Amir; Eslami, Shahram; Shamshirian, Danial; Ebrahimzadeh, Mohammad Ali
Medical Journal of Indonesia Vol. 34 No. 3 (2025): September
Publisher : Faculty of Medicine Universitas Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.13181/mji.oa.257997

Abstract

BACKGROUND Edaravone has recently been used to treat acute cerebral infarction. This study aimed to evaluate the protective effects of edaravone against hypoxia-induced lethality and oxidative stress in mice using 3 experimental models of hypoxia: asphyxia, circulatory, and hemic hypoxia. METHODS 60 Swiss albino mice from the animal facility of Mazandaran University of Medical Sciences, Iran, were randomly housed in groups of 10 during January–March 2020 and received edaravone for 4 consecutive days. After inducing hypoxia, oxidative stress, lipid peroxidation (LPO), and glutathione (GSH) content were assessed. RESULTS The findings showed significant protective effects of edaravone in all hypoxia models, with the strongest effects in asphyxia and circulatory hypoxia, showing a dose-dependent response. It prolonged survival time at 2.5 mg/kg by 26.08 (0.79) min (p = 0.031) In addition, edaravone significantly inhibited hypoxia-induced oxidative stress (LPO and GSH oxidation) in all 3 hypoxia models. CONCLUSIONS Edaravone exhibits an excellent protective effect against different models of hypoxia by decreasing oxidative stress in brain tissue. In addition, the results showed dose-dependent effects of edaravone in the asphyxia and circulatory hypoxia models. Antioxidant activity might be a proposed mechanism for the anti-hypoxic activity of this drug.
Co-Authors Ebrahimzadeh, Mohammad Ali Eslami, Shahram Mokhtaran, Mina Raei, Maedeh Razavi, Alireza Shaki, Fatemeh Shamshirian, Amir